Haematological changes after switching from stavudine to zidovudine in HIV-infected children receiving highly active antiretroviral therapy

Objective: In resource-limited countries, stavudine (d4T) is commonly used as part of the initial highly active antiretroviral therapy (HAART) regimen. Many patients who subsequently develop lipodystrophy switch from d4T to zidovudine (ZDV), a drug that can be myelotoxic. We aimed to study the spect...

Full description

Saved in:
Bibliographic Details
Main Authors: L. Aurpibul, T. Puthanakit, T. Sirisanthana, Virat Sirisanthana
Format: Journal
Published: 2018
Subjects:
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=42049088552&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/60476
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University